A detailed history of Wellington Management Group LLP transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 14,498 shares of JANX stock, worth $729,394. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,498
Previous 43,934 67.0%
Holding current value
$729,394
Previous $1.84 Million 64.24%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$35.29 - $50.26 $1.04 Million - $1.48 Million
-29,436 Reduced 67.0%
14,498 $658,000
Q2 2024

Aug 13, 2024

BUY
$35.12 - $64.78 $433,345 - $799,320
12,339 Added 39.05%
43,934 $1.84 Million
Q1 2024

May 15, 2024

BUY
$7.93 - $49.75 $250,548 - $1.57 Million
31,595 New
31,595 $1.19 Million
Q3 2021

Nov 15, 2021

SELL
$20.7 - $34.69 $189,715 - $317,933
-9,165 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$18.58 - $25.37 $170,285 - $232,516
9,165 New
9,165 $229,000

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2.1B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.